Oxaliplatin Accord Healthcare 5 mg/ml concentraat voor oplossing voor infusie clinical trials

A phase 2, single arm, open label, study on the safety and feasibility of Liver Isolated Oxaliplatin (LIOX) delivered via arterial access device for treatment of liver metastasis in colorectal cancer patients

This study looks at a new way to treat colorectal cancer that has spread to the liver. It's testing a chemotherapy drug called oxaliplatin delivered directly to the liver to see how safe and effective it is.